Company / EPS (Basic)
Foghorn Therapeutics Inc. EPS (Basic) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$1.58
FY2025
5-year range
-$6.23 / -$1.58
FY2021-FY2025
Trend
+32.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) has increased for 4 consecutive years, from $-6.23 in FY2021 to $-1.58 in FY2025.
Based on SEC 10-K filings.
-1.58 in FY2025.
Improved from $-2.62 to $-1.58 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Foghorn Therapeutics Inc.'s eps (basic) has grown for 4 consecutive years.
- In FY2025, eps (basic) increased 32.5% year-over-year.
- Lowest eps (basic) in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.58 | +32.5% |
| FY2024 | -$2.34 | +10.7% |
| FY2023 | -$2.62 | +4.0% |
| FY2022 | -$2.73 | +56.2% |
| FY2021 | -$6.23 | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026